Lennham Consumer Products

Lennham Consumer Products is a life sciences company that applies pharmaceutical-grade innovation to the consumer healthcare market. As a subsidiary of Lennham Pharmaceuticals, the company utilizes a proprietary deuterium chemistry platform to modify and improve the metabolic profiles of established consumer compounds. Their primary focus is the development of Caffeine-D, a deuterated version of caffeine intended to provide a longer-lasting and more consistent effect for consumers. The company aims to bridge the gap between traditional consumer products and advanced biotechnology through the 505(b)(2) regulatory pathway. By slowing the metabolic breakdown of active ingredients, Lennham seeks to reduce side effects and improve the overall user experience of common stimulants and supplements.